id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2002-N-0098-0003,FDA,FDA-2002-N-0098,"Agency Information Collection Activities; Proposed Collection; Comment Request; Emergency Medical Device Shortage Program
Survey",Notice,General Notice,2002-12-30T05:00:00Z,2002,12,2002-12-30T05:00:00Z,2003-03-01T04:59:59Z,2025-04-25T16:48:02Z,02-32850,0,0,090000648048e7a6
FDA-2001-P-0084-0001,FDA,FDA-2001-P-0084,FDA,Notice,N-Notice,2002-12-30T05:00:00Z,2002,12,,,2024-09-11T17:38:12Z,67FR79640,0,0,09000064804b8464
FDA-2002-N-0314-0001,FDA,FDA-2002-N-0314,Agency Information Collection Activities; Proposed Collection; Comment Request; Request for Samples and Protocols,Notice,60 Day Proposed Information Collection,2002-12-30T00:00:00Z,2002,12,2002-12-27T05:00:00Z,2003-02-26T04:59:59Z,2025-05-13T17:10:39Z,02-32749,0,0,090000648049fbad
FDA-2002-N-0028-0001,FDA,FDA-2002-N-0028,"Agency Information Collection Activities; Proposed Collection; Comment Request; Irradiation in the
Production, Processing, and Handling of Food",Notice,General Notice,2002-12-29T05:00:00Z,2002,12,2002-12-27T05:00:00Z,2003-02-26T04:59:59Z,2025-05-13T16:58:08Z,02-32662,0,0,090000648048930a
FDA-2002-N-0151-0002,FDA,FDA-2002-N-0151,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Notice of Participation,Notice,General Notice,2002-12-29T05:00:00Z,2002,12,2002-12-30T05:00:00Z,2003-01-30T04:59:59Z,2025-05-08T16:21:48Z,02-32849,0,0,09000064804929ab
FDA-2002-D-0008-0001,FDA,FDA-2002-D-0008,FDA,Notice,NAD-Notice of Availability of Data,2002-12-27T05:00:00Z,2002,12,,,2008-04-12T01:16:05Z,,0,0,09000064804874c9
FDA-1999-N-0085-0001,FDA,FDA-1999-N-0085,"SoloPak Laboratories, Inc.; Withdrawal of Approval of 1 New Drug Application and 38 Abbreviated New Drug Applications; Correction",Notice,Correction,2002-12-26T05:00:00Z,2002,12,,,2025-03-18T17:26:37Z,02-32161,0,0,09000064804a6a3d
FDA-2002-N-0152-0004,FDA,FDA-2002-N-0152,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Consumer
Surveys on Food and Dietary Supplement Labeling Issues",Notice,General Notice,2002-12-26T05:00:00Z,2002,12,2002-12-23T05:00:00Z,2003-01-23T04:59:59Z,2025-04-25T14:55:56Z,02-32160,0,0,0900006480492af2
FDA-2001-P-0028-0002,FDA,FDA-2001-P-0028,"Notice of Temporary Permit for Kraft Foods, Inc.",Notice,Notice of Temporary Permit,2002-12-23T05:00:00Z,2002,12,,,2024-08-23T15:05:38Z,,0,0,09000064804b5dff
FDA-2002-D-0179-0002,FDA,FDA-2002-D-0179,FDA,Notice,NAD-Notice of Availability of Data,2002-12-23T05:00:00Z,2002,12,2002-12-23T05:00:00Z,2003-03-20T04:59:59Z,2008-04-12T01:17:16Z,,0,0,09000064804951cb
FDA-2002-P-0251-0004,FDA,FDA-2002-P-0251,FDA,Notice,N-Notice,2002-12-23T05:00:00Z,2002,12,,,2008-04-12T01:27:49Z,,0,0,090000648049bea4
FDA-2002-D-0148-0001,FDA,FDA-2002-D-0148,Draft Guidance for Industry on the Manufacture and Labeling of Raw Meat Foods for Companion and Captive Noncompanion Carnivores and Omnivores; Availability,Notice,NAD-Notice of Availability of Data,2002-12-23T05:00:00Z,2002,12,2002-12-23T05:00:00Z,2003-03-04T04:59:59Z,2010-12-21T22:32:48Z,,0,0,09000064804925f7
FDA-2002-D-0179-0001,FDA,FDA-2002-D-0179,FDA,Notice,NAD-Notice of Availability of Data,2002-12-23T05:00:00Z,2002,12,2002-12-23T05:00:00Z,2003-03-20T04:59:59Z,2008-04-12T01:17:16Z,,0,0,09000064804951b2
FDA-2002-N-0029-0001,FDA,FDA-2002-N-0029,"Agency Information Collection Activities; Proposed Collection; Comment Request; Aluminum in Large
and Small Volume Parenterals Used in Total Parenteral Nutrition",Notice,General Notice,2002-12-22T05:00:00Z,2002,12,2002-12-19T05:00:00Z,2003-02-19T04:59:59Z,2025-05-13T15:22:30Z,02-31995,0,0,09000064804893cc
FDA-2002-N-0312-0002,FDA,FDA-2002-N-0312,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; General
Administrative Procedures: Citizen Petitions; Petition for Reconsideration or Stay of Action; Advisory Opinions",Notice,General Notice,2002-12-22T05:00:00Z,2002,12,2002-12-18T05:00:00Z,2003-01-18T04:59:59Z,2025-05-07T23:37:58Z,02-31722,0,0,090000648049fb58
FDA-2002-N-0238-0001,FDA,FDA-2002-N-0238,Medical Devices; Designation of Special Control for Eight Surgical Suture Devices,Notice,NPR-Notice of Proposed Rule-Making,2002-12-22T05:00:00Z,2002,12,2002-12-19T05:00:00Z,2003-03-20T04:59:59Z,2025-05-08T18:29:22Z,02-31991,0,0,090000648049a252
FDA-2000-N-0110-0001,FDA,FDA-2000-N-0110,FDA to Bruce I Diamond PhD - Proposal to Debar/Notice of Opportunity for Hearing,Notice,NPH-Notice of Opportunity of Hearing,2002-12-19T05:00:00Z,2002,12,,,2008-09-16T16:30:18Z,,0,0,09000064804ce234
FDA-2000-N-0225-0001,FDA,FDA-2000-N-0225,Proposal to Debar and Notice of Opportunity for Hearing Letter from FDA CDER to Richard L. Borison,Notice,Notice of Opportunity of Hearing,2002-12-19T05:00:00Z,2002,12,,,2024-12-04T03:48:42Z,,0,0,09000064804d543a
FDA-1996-P-0008-0001,FDA,FDA-1996-P-0008,FDA,Notice,NPR-Notice of Proposed Rule-Making,2002-12-17T05:00:00Z,2002,12,2002-12-13T05:00:00Z,2003-03-14T04:59:59Z,2008-05-16T22:19:29Z,,0,0,09000064804f99fe
FDA-2001-D-0060-0001,FDA,FDA-2001-D-0060,FDA,Notice,NAD-Notice of Availability of Data,2002-12-17T05:00:00Z,2002,12,,,2008-04-25T01:57:40Z,,0,0,09000064804b807c
FDA-2002-D-0052-0001,FDA,FDA-2002-D-0052,FDA,Notice,NAD-Notice of Availability of Data,2002-12-17T05:00:00Z,2002,12,2002-12-13T05:00:00Z,2003-03-14T04:59:59Z,2008-04-12T01:16:15Z,,0,0,090000648048b8c9
FDA-2001-N-0231-0002,FDA,FDA-2001-N-0231,Medical Devices; Reclassification of the Cutaneous Carbon Dioxide and the Cutaneous Oxygen Monitor,Notice,Notice of Final Rule,2002-12-17T05:00:00Z,2002,12,,,2025-02-10T16:31:24Z,02-31442,0,0,09000064804e5f44
FDA-2002-P-0210-0001,FDA,FDA-2002-P-0210,FDA,Notice,NAD-Notice of Availability of Data,2002-12-13T05:00:00Z,2002,12,2002-12-13T05:00:00Z,2003-01-09T04:59:59Z,2008-04-12T01:27:06Z,,0,0,09000064804965d7
FDA-2000-P-0063-0001,FDA,FDA-2000-P-0063,Guidance for lndustry: Guidance for lndustry: Labeling for Topically Applied Cosmetic Products Containing Alpha Hydroxy Acids as Ingredients; Availability,Notice,NAD-Notice of Availability of Data,2002-12-12T05:00:00Z,2002,12,2002-12-12T05:00:00Z,2003-02-01T04:59:59Z,2013-05-20T02:02:33Z,,0,0,09000064804af91c
FDA-2000-N-0045-0001,FDA,FDA-2000-N-0045,Laverne M. Charpentier; Final Debarment Order,Notice,N-Notice,2002-12-12T05:00:00Z,2002,12,2002-12-02T05:00:00Z,,2025-06-13T00:13:30Z,02-30482,0,0,09000064804af143
FDA-2000-N-0045-0002,FDA,FDA-2000-N-0045,Duplicate FR,Notice,,2002-12-12T00:00:00Z,2002,12,,,2024-12-03T22:23:36Z,,0,1,09000064804af151
FDA-2002-D-0174-0001,FDA,FDA-2002-D-0174,FDA,Notice,NAD-Notice of Availability of Data,2002-12-10T05:00:00Z,2002,12,,,2008-04-12T01:17:11Z,,0,0,0900006480494cc4
FDA-1997-N-0047-0001,FDA,FDA-1997-N-0047,Labeling of Diphenhydramine- Containing Drug Products for Over-the-Counter Human Use,Notice,Notice of Final Rule,2002-12-10T00:00:00Z,2002,12,2002-12-06T05:00:00Z,,2025-05-14T18:55:05Z,02-30641,0,0,09000064805cfc95
FDA-1994-D-0007-0001,FDA,FDA-1994-D-0007,FDA,Notice,NAD-Notice of Availability of Data,2002-12-04T05:00:00Z,2002,12,,,2008-05-16T23:11:39Z,,0,0,09000064804fc5c9
FDA-2002-N-0031-0002,FDA,FDA-2002-N-0031,Substances Prohibited From Use in Animal Food or Feed; Animal Proteins Prohibited in Ruminant Feed; Correction,Notice,NCR-Notice of Correction,2002-12-04T05:00:00Z,2002,12,,,2008-04-23T19:52:47Z,,0,0,09000064804896b9
FDA-2002-N-0100-0001,FDA,FDA-2002-N-0100,Bavarian Red Cross; Revocation of U.S. License No. 1002,Notice,General Notice,2002-12-04T05:00:00Z,2002,12,2002-12-03T05:00:00Z,,2025-05-13T10:01:03Z,02-30642,0,0,090000648048e8f7
FDA-2001-D-0031-0001,FDA,FDA-2001-D-0031,FDA,Notice,NAD-Notice of Availability of Data,2002-12-04T05:00:00Z,2002,12,,,2008-04-25T02:24:47Z,,0,0,09000064804b6188
FDA-2002-N-0026-0003,FDA,FDA-2002-N-0026,Agency Information Collection Activities; Announcement of OMB Approval; Veterinary Feed Directive,Notice,Notice of Approval,2002-12-04T05:00:00Z,2002,12,2002-12-03T05:00:00Z,,2025-04-30T16:49:41Z,02-30643,0,0,09000064804891bc
FDA-1990-N-0008-0001,FDA,FDA-1990-N-0008,FDA,Notice,NFR-Notice of Final Rule,2002-12-04T05:00:00Z,2002,12,,,2008-05-16T23:47:47Z,,0,0,09000064805287c2
FDA-2002-N-0231-0003,FDA,FDA-2002-N-0231,Agency Information Collection Activities; Announcement of OMB Approval; Focus Groups as Used by the Food and Drug Administration,Notice,Notice of Approval,2002-12-03T05:00:00Z,2002,12,2002-11-26T05:00:00Z,,2025-05-01T19:16:03Z,02-29927,0,0,0900006480497a33
FDA-2002-N-0060-0001,FDA,FDA-2002-N-0060,"Agency Information Collection Activities; Proposed Collection; Comment Request; Prescription Drug
Marketing Act of 1987",Notice,General Notice,2002-12-03T05:00:00Z,2002,12,2002-12-02T05:00:00Z,2003-02-01T04:59:59Z,2025-05-13T10:06:39Z,02-30404,0,0,090000648048bfc7
FDA-2002-N-0324-0001,FDA,FDA-2002-N-0324,Withdrawal of 20 Guidances on Individual Product Labeling,Notice,Withdrawal,2002-12-03T05:00:00Z,2002,12,2002-12-02T05:00:00Z,,2025-05-13T09:33:29Z,02-30481,0,0,09000064804a0b63
FDA-2002-D-0086-0001,FDA,FDA-2002-D-0086,FDA,Notice,NAD-Notice of Availability of Data,2002-12-02T05:00:00Z,2002,12,,,2008-04-12T01:16:24Z,,0,0,090000648048dd7b
FDA-2002-D-0086-0002,FDA,FDA-2002-D-0086,FDA,Notice,NAD-Notice of Availability of Data,2002-12-02T05:00:00Z,2002,12,,,2008-04-12T01:16:24Z,,0,0,090000648048ddb1
FDA-2001-N-0100-0002,FDA,FDA-2001-N-0100,Medical Devices; Classification for Medical Washer and Medical Washer-Disinfector,Notice,Notice of Final Rule,2002-12-02T05:00:00Z,2002,12,,,2025-01-29T15:34:40Z,02-28942,0,0,09000064804ba8f6
FDA-2002-N-0027-0002,FDA,FDA-2002-N-0027,Agency Information Collection Activities; Submission for OMB Review; Comment Request; Filing Objections and Requests for a Hearing on a Regulation or Order,Notice,General Notice,2002-12-01T05:00:00Z,2002,12,2002-11-29T05:00:00Z,2002-12-31T04:59:59Z,2025-05-07T21:56:53Z,02-30157,0,0,0900006480489273
FDA-1999-N-0036-0002,FDA,FDA-1999-N-0036,Notice of Approval re Agency Information Collection Activities; Announcement of OMB Approval; Food Contact Substances Notification System,Notice,Notice of Approval,2002-11-26T05:00:00Z,2002,11,2002-11-22T05:00:00Z,,2024-10-04T21:50:22Z,67FR35724,0,0,09000064804a5d6a
FDA-2002-D-0178-0001,FDA,FDA-2002-D-0178,FDA,Notice,NAD-Notice of Availability of Data,2002-11-25T05:00:00Z,2002,11,2002-11-25T05:00:00Z,2003-02-06T04:59:59Z,2008-04-12T01:17:15Z,,0,0,09000064804950f0
FDA-1994-P-0041-0004,FDA,FDA-1994-P-0041,FDA,Notice,NEC-Notice of Extension,2002-11-21T05:00:00Z,2002,11,2002-11-21T05:00:00Z,2002-12-17T04:59:59Z,2008-05-16T23:20:31Z,,0,0,09000064804febbe
FDA-2001-E-0052-0001,FDA,FDA-2001-E-0052,FDA,Notice,N-Notice,2002-11-20T05:00:00Z,2002,11,,,2008-04-25T02:25:47Z,,0,0,09000064804b7e12
FDA-2002-N-0195-0001,FDA,FDA-2002-N-0195,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Blood Establishment Registration and Product Listing, Form FDA 2830",Notice,General Notice,2002-11-20T05:00:00Z,2002,11,2002-11-19T05:00:00Z,2002-12-20T04:59:59Z,2025-05-08T23:20:38Z,02-29295,0,0,09000064804958a1
FDA-2002-E-0039-0001,FDA,FDA-2002-E-0039,Determination of Regulatory Review Period for Purposes of Patent Extension; GLEEVEC,Notice,General Notice,2002-11-20T05:00:00Z,2002,11,2002-11-18T05:00:00Z,,2025-09-30T23:40:55Z,02-29187,0,0,090000648048b33a
FDA-2000-N-0008-0002,FDA,FDA-2000-N-0008,Elaine Yee-Ling Lai; Debarment Order,Notice,General Notice,2002-11-14T05:00:00Z,2002,11,2002-11-13T05:00:00Z,,2025-06-13T00:17:48Z,02-28715,0,0,09000064804ae686
FDA-2000-N-0008-0001,FDA,FDA-2000-N-0008,Elaine Yee-Ling Lai; Debarment Order,Notice,General Notice,2002-11-14T05:00:00Z,2002,11,2002-11-13T05:00:00Z,,2025-06-13T00:17:12Z,02-28715,0,0,09000064804ae680
FDA-2001-E-0148-0001,FDA,FDA-2001-E-0148,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ACOVA",Notice,General Notice,2002-11-14T05:00:00Z,2002,11,2002-11-14T05:00:00Z,2003-01-14T04:59:59Z,2025-10-10T00:02:57Z,,0,0,09000064804ddc99
FDA-2001-E-0233-0001,FDA,FDA-2001-E-0233,"Determination of Regulatory Review Period for Purposes of Patent
Extension; COLAZAL",Notice,General Notice,2002-11-14T05:00:00Z,2002,11,2002-11-14T05:00:00Z,2003-01-14T04:59:59Z,2025-10-20T22:55:24Z,,0,0,09000064804e6151
FDA-2001-E-0149-0001,FDA,FDA-2001-E-0149,FDA,Notice,N-Notice,2002-11-14T05:00:00Z,2002,11,2002-11-14T05:00:00Z,2003-01-14T04:59:59Z,2008-04-25T02:26:25Z,,0,0,09000064804ddcba
FDA-2002-E-0336-0001,FDA,FDA-2002-E-0336,Determination of Regulatory Review Period for Purposes of Patent Extension; SOLAGE,Notice,General Notice,2002-11-14T05:00:00Z,2002,11,2002-11-14T05:00:00Z,2003-01-14T04:59:59Z,2025-09-30T19:27:12Z,02-28885,0,0,09000064804a0ca4
FDA-2002-M-0038-0001,FDA,FDA-2002-M-0038,FDA,Notice,N-Notice,2002-11-13T05:00:00Z,2002,11,,,2008-04-12T01:19:22Z,,0,0,090000648048b24e
FDA-2002-M-0282-0001,FDA,FDA-2002-M-0282,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-19T00:29:49Z,02-28155,0,0,090000648049e990
FDA-2002-M-0241-0001,FDA,FDA-2002-M-0241,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-21T17:44:48Z,02-28155,0,0,090000648049a505
FDA-2002-M-0067-0001,FDA,FDA-2002-M-0067,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-21T21:10:50Z,02-28551,0,0,090000648048c83f
FDA-2002-M-0330-0001,FDA,FDA-2002-M-0330,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-13T18:05:29Z,02-28155,0,0,09000064804a0be3
FDA-2002-N-0194-0001,FDA,FDA-2002-N-0194,"Agency Information Collection Activities; Proposed Collection; Comment Request; New Drug and
Biological Drug Products; Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethical or Feasible",Notice,General Notice,2002-11-13T05:00:00Z,2002,11,2002-11-13T05:00:00Z,2003-01-14T04:59:59Z,2025-05-13T09:43:12Z,02-28854,0,0,090000648049588f
FDA-2002-M-0239-0001,FDA,FDA-2002-M-0239,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-13T00:09:32Z,02-28155,0,0,090000648049a328
FDA-2002-M-0333-0001,FDA,FDA-2002-M-0333,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-21T19:20:19Z,02-28155,0,0,09000064804a0bff
FDA-2002-M-0203-0001,FDA,FDA-2002-M-0203,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-21T22:27:10Z,02-28155,0,0,0900006480495f5c
FDA-2002-P-0068-0001,FDA,FDA-2002-P-0068,FDA - Notice of Final Rule,Notice,NFR-Notice of Final Rule,2002-11-13T05:00:00Z,2002,11,,,2009-03-16T18:16:16Z,,0,0,090000648048c93e
FDA-2002-D-0147-0001,FDA,FDA-2002-D-0147,FDA,Notice,NAD-Notice of Availability of Data,2002-11-13T05:00:00Z,2002,11,2002-11-13T05:00:00Z,2003-01-22T04:59:59Z,2008-04-12T01:17:07Z,,0,0,0900006480492511
FDA-2002-M-0202-0001,FDA,FDA-2002-M-0202,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-19T01:15:59Z,02-28155,0,0,0900006480495e9f
FDA-2002-M-0158-0001,FDA,FDA-2002-M-0158,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-19T01:02:10Z,02-28155,0,0,0900006480493e69
FDA-2002-M-0117-0001,FDA,FDA-2002-M-0117,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-21T01:17:33Z,02-28155,0,0,09000064804900c6
FDA-2002-M-0201-0001,FDA,FDA-2002-M-0201,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-12T23:51:01Z,02-28155,0,0,0900006480495dc4
FDA-2002-N-0275-0002,FDA,FDA-2002-N-0275,"Agency Information Collection Activities; Submission for OMB Review; Comment Request; Medical
Device Recall Authority",Notice,General Notice,2002-11-13T05:00:00Z,2002,11,2002-11-13T05:00:00Z,2002-12-14T04:59:59Z,2025-05-13T02:28:19Z,02-28713,0,0,090000648049e491
FDA-2002-M-0334-0001,FDA,FDA-2002-M-0334,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-21T19:57:09Z,02-28155,0,0,09000064804a0c0d
FDA-2002-M-0037-0001,FDA,FDA-2002-M-0037,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-25T17:19:16Z,02-28155,0,0,090000648048b183
FDA-2002-M-0281-0001,FDA,FDA-2002-M-0281,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-26T18:24:54Z,02-28155,0,0,090000648049e8e7
FDA-2001-P-0215-0001,FDA,FDA-2001-P-0215,FDA,Notice,N-Notice,2002-11-13T05:00:00Z,2002,11,,,2024-08-12T20:41:36Z,,0,0,09000064804e4832
FDA-2002-M-0157-0001,FDA,FDA-2002-M-0157,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-13T01:24:22Z,02-28155,0,0,0900006480493dc2
FDA-2002-M-0204-0001,FDA,FDA-2002-M-0204,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-12T23:02:47Z,02-28155,0,0,0900006480496029
FDA-2002-M-0280-0001,FDA,FDA-2002-M-0280,Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications,Notice,Notice of Data Availability,2002-11-13T05:00:00Z,2002,11,,,2025-08-21T22:11:23Z,02-28155,0,0,090000648049e834
FDA-2000-D-0032-0001,FDA,FDA-2000-D-0032,FDA,Notice,NAD-Notice of Availability of Data,2002-11-12T05:00:00Z,2002,11,2002-11-12T05:00:00Z,2003-02-11T04:59:59Z,2008-04-25T01:12:51Z,,0,0,09000064804aed2a
FDA-2002-D-0021-0002,FDA,FDA-2002-D-0021,FDA,Notice,NAD-Notice of Availability of Data,2002-11-12T05:00:00Z,2002,11,2002-11-12T05:00:00Z,2003-11-14T04:59:59Z,2008-04-12T01:16:12Z,,0,0,0900006480488d1e
FDA-2002-N-0018-0002,FDA,FDA-2002-N-0018,FDA,Notice,NFR-Notice of Final Rule,2002-11-12T05:00:00Z,2002,11,,,2008-04-12T01:20:15Z,,0,0,0900006480488ab2
FDA-2002-D-0309-0001,FDA,FDA-2002-D-0309,FDA,Notice,NAD-Notice of Availability of Data,2002-11-08T05:00:00Z,2002,11,2002-11-08T05:00:00Z,2003-01-06T04:59:59Z,2008-04-12T01:18:32Z,,0,0,090000648049f958
FDA-2002-D-0190-0001,FDA,FDA-2002-D-0190,FDA,Notice,NAD-Notice of Availability of Data,2002-11-07T05:00:00Z,2002,11,2002-11-07T05:00:00Z,2003-11-02T04:59:59Z,2008-04-12T01:17:28Z,,0,0,0900006480495825
FDA-2001-D-0041-0002,FDA,FDA-2001-D-0041,FDA,Notice,NAD-Notice of Availability of Data,2002-11-07T05:00:00Z,2002,11,2002-11-07T05:00:00Z,2003-11-02T04:59:59Z,2008-04-25T02:25:33Z,,0,0,09000064804b6f7a
FDA-1985-N-0022-0013,FDA,FDA-1985-N-0022,Notice of Withdrawal re Drug Price Competition & Patent Term Restoration Act 1984,Notice,Withdrawal,2002-11-07T05:00:00Z,2002,11,,,2016-03-02T16:35:15Z,,0,0,09000064805b3c35
FDA-2002-D-0220-0002,FDA,FDA-2002-D-0220,FDA,Notice,NCR-Notice of Correction,2002-11-07T05:00:00Z,2002,11,,,2008-04-12T01:17:28Z,,0,0,0900006480496f29
FDA-2002-N-0097-0003,FDA,FDA-2002-N-0097,FDA,Notice,NAL-Notice of Approval,2002-11-01T05:00:00Z,2002,11,,,2008-04-12T01:21:48Z,,0,0,090000648048e6d9
FDA-2002-N-0103-0001,FDA,FDA-2002-N-0103,"Solicitation of Public Review and Comment on Research Protocol: A Multicenter, Randomized Dose Response Study of the Safety, Clinical and Immune Response of Dryvax Administered to Children 2 to 5 Years of Age",Notice,N-Notice,2002-11-01T05:00:00Z,2002,11,2002-11-01T05:00:00Z,2002-12-03T04:59:59Z,2009-04-28T14:55:26Z,,0,0,090000648048eb23
FDA-2002-N-0095-0001,FDA,FDA-2002-N-0095,Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of a Claim for Generally Recognized as Safe Exemption Based on a Generally Recognized as Safe Determination,Notice,60 Day Proposed Information Collection,2002-11-01T05:00:00Z,2002,11,2002-10-31T05:00:00Z,2002-12-31T04:59:59Z,2017-09-13T18:19:14Z,02–27741,0,0,090000648048e544
FDA-2002-N-0095-0002,FDA,FDA-2002-N-0095,Agency Information Collection Activities; Proposed Collection; Comment Request; Notice of a Claim for Generally Recognized as Safe Exemption Based on a Generally Recognized as Safe Determination,Notice,60 Day Proposed Information Collection,2002-11-01T05:00:00Z,2002,11,2002-10-31T05:00:00Z,2002-12-31T04:59:59Z,2017-08-29T16:09:49Z,02–27741,0,0,090000648048e57c
FDA-2002-N-0097-0004,FDA,FDA-2002-N-0097,FDA,Notice,NAL-Notice of Approval,2002-11-01T05:00:00Z,2002,11,,,2008-04-12T01:21:48Z,,0,0,090000648048e6db
FDA-2002-N-0108-0001,FDA,FDA-2002-N-0108,FDA,Notice,N-Notice,2002-10-29T05:00:00Z,2002,10,2002-10-29T05:00:00Z,2002-11-27T04:59:59Z,2008-04-12T01:22:14Z,,0,0,090000648048f88a
FDA-2002-N-0319-0001,FDA,FDA-2002-N-0319,Antimicrobial Drug Development: Public Workshop Meeting (11/19-20/2002) - Notice of Meeting,Notice,NM-Notice of Meeting,2002-10-29T05:00:00Z,2002,10,,,2009-03-08T15:02:42Z,,0,0,09000064804a00a5
FDA-2002-N-0108-0002,FDA,FDA-2002-N-0108,FDA,Notice,NCR-Notice of Correction,2002-10-29T05:00:00Z,2002,10,,,2008-04-12T01:22:15Z,,0,0,090000648048f8c9
FDA-2002-N-0279-0001,FDA,FDA-2002-N-0279,FDA - Notice of Proposed Rule-Making,Notice,NPR-Notice of Proposed Rule-Making,2002-10-28T05:00:00Z,2002,10,2002-10-28T05:00:00Z,2002-12-24T04:59:59Z,2009-03-09T17:41:56Z,,0,0,090000648049e6ba
FDA-2002-N-0265-0001,FDA,FDA-2002-N-0265,FDA,Notice,NHC-Notice of Hearing Before Commissioner,2002-10-28T05:00:00Z,2002,10,2002-10-28T05:00:00Z,2003-01-25T04:59:59Z,2008-04-12T01:24:26Z,,0,0,090000648049c895
FDA-2002-N-0230-0005,FDA,FDA-2002-N-0230,Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Adverse Drug Experience Reporting,Notice,Notice of Approval,2002-10-25T04:00:00Z,2002,10,2002-10-23T04:00:00Z,,2025-04-23T14:03:36Z,02-26914,0,0,0900006480497973
FDA-1984-F-0013-0001,FDA,FDA-1984-F-0013,Quest International,Notice,NWL-Notice of Withdrawl,2002-10-25T04:00:00Z,2002,10,,,2008-05-30T22:52:41Z,,0,0,09000064805a7ecb
FDA-2000-C-0234-0003,FDA,FDA-2000-C-0234,Listing of Color Additives Exempt From Certification; Mica-Based Pearlescent Pigments,Notice,Notice of Final Rule,2002-10-25T04:00:00Z,2002,10,2002-10-25T04:00:00Z,2002-11-26T04:59:59Z,2025-07-03T18:45:16Z,,0,0,09000064804d580b
FDA-2001-E-0117-0003,FDA,FDA-2001-E-0117,Determination of Regulatory Review Period for Purposes of Patent Extension; MIFEREX; Amendment - Notice,Notice,N-Notice,2002-10-25T04:00:00Z,2002,10,,,2010-03-12T16:13:43Z,,0,0,09000064804bbeec
FDA-2002-N-0230-0004,FDA,FDA-2002-N-0230,Agency Information Collection Activities; Announcement of OMB Approval; Postmarketing Adverse Drug Experience Reporting,Notice,Notice of Approval,2002-10-25T04:00:00Z,2002,10,2002-10-23T04:00:00Z,,2025-04-23T14:00:44Z,02-26914,0,0,0900006480497970
FDA-2002-D-0023-0001,FDA,FDA-2002-D-0023,FDA,Notice,NAD-Notice of Availability of Data,2002-10-22T04:00:00Z,2002,10,2002-10-22T04:00:00Z,2003-01-22T04:59:59Z,2008-04-12T01:16:14Z,,0,0,0900006480488eb7